Exome sequencing to identify de novo mutations in sporadic ALS trios

Nature Neuroscience

Volumn 16, Issue 7, 2013, Pages 851-855

  Chesi, Alessandra ^a   Staahl, Brett T ^a   Jovičić, Ana ^a   Couthouis, Julien ^a   Fasolino, Maria ^b   Raphael, Alya R ^a   Yamazaki, Tomohiro ^c   Elias, Laura ^a   Polak, Meraida ^d   Kelly, Crystal ^d   Williams, Kelly L ^e,f,g   Fifita, Jennifer A ^e,g   Maragakis, Nicholas J ^h   Nicholson, Garth A ^e,f   King, Oliver D ⁱ   Reed, Robin ^c   Crabtree, Gerald R ^a   Blair, Ian P ^e,f,g   Glass, Jonathan D ^d   Gitler, Aaron D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Australian and New Zealand Army Corps Research Institute   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g MACQUARIE UNIVERSITY   (Australia)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; FUSED IN SARCOMA PROTEIN; BANF1 PROTEIN, HUMAN; DNA BINDING PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MTAP2 PROTEIN, MOUSE; NUCLEAR PROTEIN; RNA BINDING PROTEIN; SS18L1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CLINICAL ARTICLE; CONTROLLED STUDY; EXOME; GENE MUTATION; GENE SEQUENCE; GENETIC RISK; HUMAN; MISSENSE MUTATION; MOUSE; NERVE CELL; NERVE FIBER GROWTH; NONHUMAN; PARENT; PRIORITY JOURNAL; REGULATOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; ANIMAL EMBRYO; BRAIN CORTEX; CELL CULTURE; CYTOLOGY; DENDRITE; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MALE; METABOLISM; MIDDLE AGED; MOTONEURON; MUTATION; PHYSIOLOGY; YOUNG ADULT;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; DENDRITES; DNA-BINDING PROTEINS; EMBRYO, MAMMALIAN; EXOME; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOTOR NEURONS; MUTATION; NUCLEAR PROTEINS; RNA-BINDING PROTEIN FUS; TRANS-ACTIVATORS; YOUNG ADULT;

EID: 84887404098     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3412     Document Type: Article

References (56)

1. Andersen, P.M. & Al-Chalabi, A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat. Rev. Neurol. 7, 603-615 (2011).
2. Sreedharan, J. et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672 (2008).
3. Vance, C. et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211 (2009).
4. Kwiatkowski, T.J. et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208 (2009).
5. Johnson, J.O. et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68, 857-864 (2010).
6. Maruyama, H. et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465, 223-226 (2010).
7. Deng, H.X. et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477, 211-215 (2011).
8. Wu, C.H. et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 488, 499-503 (2012).
9. DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245-256 (2011).
10. Renton, A.E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257-268 (2011).
11. Rosen, D.R. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62 (1993).
12. O'Roak, B.J. et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246-250 (2012).
13. Neale, B.M. et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242-245 (2012).
14. Sanders, S.J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237-241 (2012).
15. Iossifov, I. et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285-299 (2012).
16. Xu, B. et al. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nat. Genet. 43, 864-868 (2011).
17. Girard, S.L. et al. Increased exonic de novo mutation rate in individuals with schizophrenia. Nat. Genet. 43, 860-863 (2011).
18. Vissers, L.E. et al. A de novo paradigm for mental retardation. Nat. Genet. 42, 1109-1112 (2010).
19. Alexander, M.D. et al. "True" sporadic ALS associated with a novel SOD-1 mutation. Ann. Neurol. 52, 680-683 (2002).
20. Chiò, A. et al. A de novo missense mutation of the FUS gene in a "true" sporadic ALS case. Neurobiol. Aging 32, e23-e26 (2011).
21. DeJesus-Hernandez, M. et al. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis. Hum. Mutat. 31, E1377-E1389 (2010).
22. Huang, D.W. et al. Extracting biological meaning from large gene lists with DAVID. Curr. Protoc. Bioinformatics Chapter 13, 13.11 (2009).
23. Ryu, H. et al. Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. J. Neurochem. 93, 1087-1098 (2005).
24. Rouaux, C. et al. Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms, but does not improve survival in an amyotrophic lateral sclerosis mouse model. J. Neurosci. 27, 5535-5545 (2007).
25. Egawa, N. et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl. Med. 4, 145ra104 (2012).
26. Cudkowicz, M.E. et al. Phase 2 study of sodium phenylbutyrate in ALS. Amyotroph. Lateral Scler. 10, 99-106 (2009).
27. Gil, O.D., Zanazzi, G., Struyk, A.F. & Salzer, J.L. Neurotrimin mediates bifunctional effects on neurite outgrowth via homophilic and heterophilic interactions. J. Neurosci. 18, 9312-9325 (1998).
28. van Horck, F.P., Lavazais, E., Eickholt, B.J., Moolenaar, W.H. & Divecha, N. Essential role of type I(alpha) phosphatidylinositol 4-phosphate 5-kinase in neurite remodeling. Curr. Biol. 12, 241-245 (2002).
29. Aizawa, H. et al. Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. Science 303, 197-202 (2004).
30. Qiu, Z. & Ghosh, A. A calcium-dependent switch in a CREST-BRG1 complex regulates activity-dependent gene expression. Neuron 60, 775-787 (2008).
31. Wu, J.I. et al. Regulation of dendritic development by neuron-specific chromatin remodeling complexes. Neuron 56, 94-108 (2007).
32. Kabashi, E. et al. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum. Mol. Genet. 19, 671-683 (2010).
33. Khavari, P.A., Peterson, C.L., Tamkun, J.W., Mendel, D.B. & Crabtree, G.R. BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription. Nature 366, 170-174 (1993).
34. Fujii, R. et al. The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr. Biol. 15, 587-593 (2005).
35. Cushman, M., Johnson, B.S., King, O.D., Gitler, A.D. & Shorter, J. Prion-like disorders: blurring the divide between transmissibility and infectivity. J. Cell Sci. 123, 1191-1201 (2010).
36. Gitler, A.D. & Shorter, J. RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion 5, 179-187 (2011).
37. King, O.D., Gitler, A.D. & Shorter, J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 1462, 61-80 (2012).
38. Couthouis, J. et al. A yeast functional screen predicts new candidate ALS disease genes. Proc. Natl. Acad. Sci. USA 108, 20881-20890 (2011).
39. Couthouis, J. et al. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 21, 2899-2911 (2012).
40. Kim, H.J. et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495, 467-473 (2013).
41. Monroy, M.A. et al. Regulation of cAMP-responsive element-binding protein-mediated transcription by the SNF2/SWI-related protein, SRCAP. J. Biol. Chem. 276, 40721-40726 (2001).
42. Wang, X. et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454, 126-130 (2008).
43. Bultman, S. et al. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol. Cell 6, 1287-1295 (2000).
44. Tsurusaki, Y. et al. Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. Nat. Genet. 44, 376-378 (2012).
45. Wolff, D. et al. In-frame deletion and missense mutations of the C-terminal helicase domain of SMARCA2 in three patients with Nicolaides-Baraitser syndrome. Mol. Syndromol. 2, 237-244 (2012).
46. Van Houdt, J.K. et al. Heterozygous missense mutations in SMARCA2 cause Nicolaides-Baraitser syndrome. Nat. Genet. 44, 445-449 (2012).
47. Hoyer, J. et al. Haploinsufficiency of ARID1B, a member of the SWI/SNF-a chromatin-remodeling complex, is a frequent cause of intellectual disability. Am. J. Hum. Genet. 90, 565-572 (2012).
48. Loe-Mie, Y. et al. SMARCA2 and other genome-wide supported schizophrenia-associated genes: regulation by REST/NRSF, network organization and primate-specific evolution. Hum. Mol. Genet. 19, 2841-2857 (2010).
49. Lule, D., Ludolph, A.C. & Ludolph, A.G. Neurodevelopmental and neurodegenerative diseases: is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples. Med. Hypotheses 70, 1133-1138 (2008).
50. Calvo, A.C. et al. Genetic biomarkers for ALS disease in transgenic SOD1(G93A) mice. PLoS ONE 7, e32632 (2012).
51. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
52. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
53. DePristo, M.A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491-498 (2011).
54. Hosack, D.A., Dennis, G. Jr., Sherman, B.T., Lane, H.C. & Lempicki, R.A. Identifying biological themes within lists of genes with EASE. Genome Biol. 4, R70 (2003).
55. Dufu, K. et al. ATP is required for interactions between UAP56 and two conserved mRNA export proteins, Aly and CIP29, to assemble the TREX complex. Genes Dev. 24, 2043-2053 (2010).
56. Folco, E.G., Lei, H., Hsu, J.L. & Reed, R. Small-scale nuclear extracts for functional assays of gene-expression machineries. J. Vis. Exp. 64, e4140 (2012).